REVIEW ARTICLE
Year : 2023 | Volume
: 14 | Issue : 2 | Page : 71--77
Approaches to multiple myeloma management in gulf countries: A narrative review insights from the Kingdom of Saudi Arabia and gulf multiple myeloma experts
Fahad Z Al Sharif1, Ahmad Alhuraiji2, Arif Alam3, Ayman Alhejazi4, Hani Osman3, Hesham El Sabah5, Faraz Khan6, Majed Alahmadi7, Musa Alzahrani8, Mustaqeem A Siddiqi9, Omar Zeid Abdeljalil10, Ahmed Hesham11, Magdy Rabea11, Waleed Hannout11, Mahmoud Marashi12
1 Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2 Department of Hematology, Kuwait Cancer Control Center, Kuwait City, Kuwait
3 Department of Oncology, Tawam Hospital, Dubai, Saudi Arabia
4 Department of Oncology, King Abdulaziz Medical City, Dubai, Saudi Arabia
5 Hamad Medical Corporation, National Center for Cancer Care and Research, Dubai, Saudi Arabia
6 Department of Oncology, American Hospital, Dubai, Saudi Arabia
7 Department of Adult Hematology and HSCT, King AbdulAziz Medical City, King Saud bin Abdul Aziz University for Health Sciences, Riyadh, Saudi Arabia
8 Department of Medicine and Oncology Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
9 Division of Oncology and Hematology, Sheikh Shakhbout Medical City, Abu Dhabi, Saudi Arabia
10 Department of Oncology, King Fahd Specialist Hospital in Dammam, Dammam, Saudi Arabia
11 Department of Medical Affairs, Sanofi, GCC, Dubai, UAE
12 Department of Hematology, Dubai Health Authority, Mediclinic City Hospital, Dubai, UAE
Correspondence Address:
Dr. Mahmoud Marashi
Department of Hematology, Dubai Health Authority, Mediclinic City Hospital, Dubai
UAE
Multiple myeloma (MM) is neoplasm of the plasma cells derived from the postgerminal B-cell lineage and it ranges from premalignant conditions like monoclonal gammopathy of unknown significance and smoldering MM (SMM) to malignant diseases such as overt MM. With advances in science and technology, the understanding of the disease has increased paving the way for advanced therapeutic options and better patient outcomes. Thus, this article is a narrative review summarizing the recent advances in the epidemiology, clinical presentation, risk stratification, and MM patient populations treatment and to provide insights by the authors who are experts in the field of MM management who are considered as Gulf Myeloma Working Group and who were the members of 'Approaches to MM Management' Advisory Board meeting held on October 29, 2021. The expert panel provided several recommendations and drawn consensus statements pertaining to MM management in the Gulf countries.
How to cite this article:
Al Sharif FZ, Alhuraiji A, Alam A, Alhejazi A, Osman H, El Sabah H, Khan F, Alahmadi M, Alzahrani M, Siddiqi MA, Abdeljalil OZ, Hesham A, Rabea M, Hannout W, Marashi M. Approaches to multiple myeloma management in gulf countries: A narrative review insights from the Kingdom of Saudi Arabia and gulf multiple myeloma experts.J Appl Hematol 2023;14:71-77
|
How to cite this URL:
Al Sharif FZ, Alhuraiji A, Alam A, Alhejazi A, Osman H, El Sabah H, Khan F, Alahmadi M, Alzahrani M, Siddiqi MA, Abdeljalil OZ, Hesham A, Rabea M, Hannout W, Marashi M. Approaches to multiple myeloma management in gulf countries: A narrative review insights from the Kingdom of Saudi Arabia and gulf multiple myeloma experts. J Appl Hematol [serial online] 2023 [cited 2023 Oct 2 ];14:71-77
Available from: https://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=2;spage=71;epage=77;aulast=Al;type=0 |
|
